The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The administration of single oral doses of delta‐9‐tetrahydrocannabinol (THC) to patients with cancer pain demonstrated a mild analgesic effect. At a dose of 20 mg, however, THC induced side effects that would prohibit its therapeutic use including somnolence, dizziness, ataxia, and blurred vision. Alarming adverse reactions were also observed at this dose. THC, 10 mg, was well tolerated and, despite its sedative effect, may have analgesic potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Keele, K. D. (1948) · The Lancet · doi:10.1016/s0140-6736(48)91787-5 · Cited by 241
Ames, F. (1958) · Journal of Mental Science · doi:10.1192/bjp.104.437.972 · Cited by 184
Snyder, S. H. (1971) · Medical Entomology and Zoology · Cited by 30
Cited by
Items 101–200 of 376
Spinal mechanisms ofΔ9-tetrahydrocannabinol-induced analgesia
Smith, P. B., & Martin, B. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)90222-u · Cited by 91
Naloxone-induced or postwithdrawal abstinence signs in ?9-Tetrahydrocannabinol-Tolerant rats
Kaymak�alan, �., Ayhan, I. H., & Tulunay, F. C. (1977) · Psychopharmacology · doi:10.1007/bf00497855 · Cited by 91
Lal, S., Shekher, A., Puneet, Narula, A. S., Abrahamse, H., & Gupta, S. C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105302 · Cited by 98
Naef, M., Russmann, S., Petersen‐Felix, S., & Brenneisen, R. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20037 · Cited by 88
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms
DeVuono, M. V., & Parker, L. A. (2020) · Cannabis & Cannabinoid Research · doi:10.1089/can.2019.0059 · Cited by 87
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
Burns, T. L., & Ineck, J. R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g217 · Cited by 84
Darmani, N. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01355-3 · Cited by 91
(1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.12.1976 · Cited by 87
On the Pharmacological Properties of Δ9‐Tetrahydrocannabinol (THC)
Costa, B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790146 · Cited by 97
The pharmacological basis of contemporary pain management
MacPherson, R. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00090-5 · Cited by 89
Human Studies of Cannabinoids and Medicinal Cannabis
Robson, P. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_25 · Cited by 94
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms
Darmani, N. A. (2010) · Pharmaceuticals · doi:10.3390/ph3072163 · Cited by 75
Hazekamp, A., Fischedick, J. T., Díez, M. L., Lubbe, A., & Ruhaak, L. R. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00091-5 · Cited by 106
Medicinal Uses of Marijuana and Cannabinoids
Grotenhermen, F., & Müller‐Vahl, K. (2016) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2016.1265360 · Cited by 88
Codeine, alone and with paracetamol (acetaminophen), for cancer pain
Straube, C., Derry, S., Jackson, K. C., Wiffen, P. J., Bell, R. F., Strassels, S. A., & Straube, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006601.pub4 · Cited by 89
Pharmacology and potential therapeutic uses of cannabis
Hirst, R. A., Lambert, D. G., & Notcutt, W. G. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.77 · Cited by 80
Cannabis and Cannabinoids: Pharmacology and Rationale for Clinical Use
Pertwee, R. G. (1999) · Complementary Medicine Research · doi:10.1159/000057150 · Cited by 67
Cannabinoids as potential new analgesics
Fuentes, J., Ruiz‐Gayo, M., Manzanares, J., Vela, G., Reche, I., & Corchero, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00290-8 · Cited by 72
Wiffen, P. J., Derry, S., & Moore, R. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011056.pub2 · Cited by 84
Cannabinoids in acute gastric damage and pancreatitis.
DEMBINSKI, A. B., Warzecha, Z., Ceranowicz, P., Dembiński, M., Cieszkowski, J., Pawlik, W. W., Konturek, S. J., Tomaszewska, R., Hładki, W., & Konturek, P. C. (2006) · PubMed · Cited by 79
Breast cancer pain management - a review of current & novel therapies.
Satija, A., Ahmed, S., Gupta, R. K., Ahmed, A., Rana, S. P. S., Singh, S. P., Mishra, S., & Bhatnagar, S. (2014) · PubMed Central · Cited by 74
Should Cannabinoids Be Added to Multimodal Pain Regimens After Total Hip and Knee Arthroplasty?
Hickernell, T. R., Lakra, A., Berg, A. R., Cooper, H. J., Geller, J. A., & Shah, R. P. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.07.027 · Cited by 71
Use of Cannabis and Cannabinoids for Treatment of Cancer
Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022) · Cancers · doi:10.3390/cancers14205142 · Cited by 78
Hemp for Headache: An In-Depth Historical and Scientific Review of Cannabis in Migraine Treatment
Russo, E. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n02_04 · Cited by 66
“A similarly composed research group compared the analgesic effect of THC was compared to codeine (Noyes et al. 1975).”
ResultOpioid analgesics for nociceptive cancer pain: A comprehensive review
Shaheed, C. A., Hayes, C., Maher, C. G., Ballantyne, J. C., Underwood, M. R., McLachlan, A. J., Martin, J. H., Narayan, S. W., & Sidhom, M. A. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21823 · Cited by 109
“Seven trials 32,34,37,39,84–86 ( n = 379) identified from a 2018 Cochrane review 29 evaluated different strengths of codeine or codeine compared with another opioid.”
BackgroundRabgay, K., Waranuch, N., Chaiyakunapruk, N., Sawangjit, R., Ingkaninan, K., & Dilokthornsakul, P. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.07.015 · Cited by 77
Marijuana in the management of amyotrophic lateral sclerosis
Carter, G. T., & Rosen, B. S. (2001) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/104990910101800411 · Cited by 67
Cannabis-based medicines and medical cannabis for adults with cancer pain
Häuser, W., Welsch, P., Radbruch, L., Fisher, E., Bell, R. F., & Moore, A. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014915.pub2 · Cited by 108
Integrative Therapies in Cancer Care: An Update on the Guidelines
Gowin, K. L., Muminovic, M., Zick, S. M., Lee, R. T., Lacchetti, C., & Mehta, A. (2024) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_431554 · Cited by 76
The use of cannabis in supportive care and treatment of brain tumor
Likar, R., & Nahler, G. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npw027 · Cited by 66
Schwitzer, T., Schwan, R., Angioï-Duprez, K., Ingster-Moati, I., Lalanne, L., Giersch, A., & Laprévote, V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.002 · Cited by 73
Cannabis use in sickle cell disease: a questionnaire study
Howard, J., Anie, K. A., Holdcroft, A., Israeli‐Korn, S., & Davies, S. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05723.x · Cited by 65
Kalliomäki, J., Segerdahl, M., Webster, L. R., Reimfelt, A., Huizar, K., Annas, P., Karlsten, R., & Quiding, H. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2012.08.004 · Cited by 64
Harris, D., Jones, R. T., Shank, R., Nath, R., Fernandez, E., Goldstein, K., & Mendelson, J. (2000) · Journal of Addictive Diseases · doi:10.1300/j069v19n03_07 · Cited by 60
“The most commonly reported marijuana side effects which influenced the severity rating were memory or concentration problems (n = 11); ‘‘cotton mouth’’ or dry mouth or throat (7); cough (5); and feeling tired (6), hungry (6), or drowsy (5).”
BackgroundKalliomäki, J., Annas, P., Huizar, K., Clarke, C. P., Zettergren, A., Karlsten, R., & Segerdahl, M. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12051 · Cited by 63
Turgeman, I., & Bar‐Sela, G. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2019.1561859 · Cited by 72
“demonstrated, with a small sample size, that high doses of Δ(9)-THC were significantly superior to placebo in pain reduction and comparable to codeine, however, were associated with considerable sedation [32].”
BackgroundTherapeutic potential of cannabinoid receptor agonists as analgesic agents
Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60
Goodwin, R. S., Gustafson, R. A., Barnes, A. J., Nebro, W., Moolchan, E. T., & Huestis, M. A. (2006) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200608000-00010 · Cited by 61
Medical Management of Chronic Cancer Pain
Shimm, D. S. (1979) · JAMA · doi:10.1001/jama.1979.03290480042022 · Cited by 56
Mawatari, H., Shinjo, T., Morita, T., Kohara, H., & Yomiya, K. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0438 · Cited by 64
Medical Cannabis for Chronic Nonmalignant Pain Management
Hameed, M., Prasad, S., Jain, E., Doğrul, B. N., Al-Oleimat, A., Pokhrel, B., Chowdhury, S., Co, E. L., Mitra, S., Quinonez, J., et al. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01101-w · Cited by 72
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C
Sylvestre, D. L., Clements, B. J., & Malibu, Y. (2006) · European Journal of Gastroenterology & Hepatology · doi:10.1097/01.meg.0000216934.22114.51 · Cited by 54
Clinical Pharmacokinetics of Cannabinoids
Grotenhermen, F. (2003) · Journal of Cannabis Therapeutics · doi:10.1300/j175v03n01_02 · Cited by 63
Hamamoto, D. T., Giridharagopalan, S., & Simone, D. A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.062 · Cited by 57
The Pharmacological History of Cannabis
Russo, E. B. (2014) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199662685.003.0002 · Cited by 67
The central cannabinoid receptor type-2 (CB2) and chronic pain
Shang, Y.-C., & Tang, Y. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1257992 · Cited by 60
Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat
Kandasamy, R., Dawson, C. T., Craft, R. M., & Morgan, M. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.054 · Cited by 49
“…for a wide range of pain conditions (Chiou et al., 2013; Craft et al., 2013; Karst et al., 2010; Kraft, 2012; Maione et al., 2013; Milstein et al., 1975; Noyes and Baram, 1974; Noyes et al., 1975), it is not surprising that some people use marijuana as a treatment for migraine (el-Mallakh, 1989).”
Potenzieri, C., Harding-Rose, C., & Simone, D. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.063 · Cited by 54
“A study using Δ-9-tetrahydrocannabinol, the main psychoactive component of cannabis, found its analgesic efficacywas similar to codeine inpatientswith cancer pain (Noyes et al., 1975).”
BackgroundCannabis in Palliative Care: A Systematic Review of Current Evidence
Doppen, M., Kung, S. M., Maijers, I., John, M., Dunphy, H., Townsley, H., Eathorne, A., Semprini, A. C., & Braithwaite, I. E. (2022) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2022.06.002 · Cited by 54
Cannabis and cannabinoids in cancer pain management
Meng, H., Dai, T., Hanlon, J. G., Downar, J., Alibhai, S. M. H., & Clarke, H. A. (2020) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0000000000000493 · Cited by 62
“A subsequent study with 36 patients demonstrated that 10 mg THC produced a comparable amount of pain relief to 60 mg codeine, and comparable sedation to 120 mg codeine [10].”
BackgroundCannabis and endocannabinoid modulators: Therapeutic promises and challenges
Grant, I., & Cahn, B. R. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.015 · Cited by 63
“In brief, there were contradictory findings in human studies on pain, with some research suggesting that THC relieved cancer pain about as well as 60 mg of codeine [56,57] and that levonantrodol, a synthetic THC-like cannabinoid was effective in post-operative and trauma pain [58].”
ResultPractical Aspects of Pain Control In the Patient with Cancer
Portenoy, R. K. (1988) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.38.6.327 · Cited by 49
Medical cannabis: considerations for the anesthesiologist and pain physician
Beaulieu, P., Boulanger, A., Desroches, J., & Clark, A. J. (2016) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-016-0598-x · Cited by 54
Phytomedicines in the Treatment of Migraine
Rajapakse, T., & Davenport, W. J. (2019) · CNS Drugs · doi:10.1007/s40263-018-0597-2 · Cited by 60
Steele, G. L., Arneson, T. J., & Zylla, D. M. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0757-7 · Cited by 56
Walker, J. M., Strangman, N. M., & Huang, S. M. (2001) · Pain Research and Management · doi:10.1155/2001/413641 · Cited by 47
Bouskila, J., Burke, M., Zabouri, N., Casanova, C., Ptito, M., & Bouchard, J. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.041 · Cited by 53
“…1978), a reduction in Vernier and Snellen acuities (Adams et al., 1975; Kiplinger et al., s p t h r a p a r c b r t t i e t o t s o a l t c t k t w e p t s a rence, an 1971), blurred vision (Noyes et al., 1975), change in color discrimination, and increased photosensitivity (Dawson et al., 1977).”
BackgroundIs There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Kraft, B. (2012) · Pharmacology · doi:10.1159/000337376 · Cited by 50
Medical cannabis for chronic pain: can it make a difference in pain management?
Maharajan, M. K., Yong, Y. J., Yip, H. Y., Woon, S. S., Yeap, K. M., Yap, K. Y., Yip, S. C., & Yap, K. X. (2019) · Journal of Anesthesia · doi:10.1007/s00540-019-02680-y · Cited by 52
Medical Efficacy of Cannabinoids and Marijuana: A Comprehensive Review of the Literature
Bagshaw, S. M., & Hagen, N. A. (2002) · Journal of Palliative Care · doi:10.1177/082585970201800207 · Cited by 49
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events
To, J., Davis, M., Sbrana, A., Alderman, B., Hui, D., Mukhopadhyay, S., Bouleuc, C., Case, A., Amano, K., Crawford, G., et al. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07662-1 · Cited by 38
Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain
Dhaliwal, H., Sloan, P. A., Arkinstall, W. W., Thirlwell, M. P., Babul, N., Harsanyi, Z., & Darke, A. C. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00123-9 · Cited by 43
Ang, S. P., Sidharthan, S., Lai, W. C., Hussain, N., Patel, K. V., Gulati, A., Henry, O., Kaye, A. D., & Orhurhu, V. (2023) · Pain and Therapy · doi:10.1007/s40122-022-00465-y · Cited by 49
“However, only the high doses of THC and codeine showed a statistically significant difference in pain relief compared with placebo [60].”
BackgroundMücke, M., Carter, C., Cuhls, H., Prüß, M. S., Radbruch, L., & Häuser, W. (2016) · Der Schmerz · doi:10.1007/s00482-015-0085-2 · Cited by 41
“Dies zeigte beispielsweise die offene Anschlussstudie der Studie von Johnson et al. [14] mit einer mittleren Studiendauer von 151 Tagen (Minimum 4, Maximum 657 Tage) und 43 Tumorpatienten.”
BackgroundInfluentialOpioid use and misuse: health impact, prevalence, correlates and interventions
Bolshakova, M., Bluthenthal, R. N., & Sussman, S. Y. (2019) · Psychology and Health · doi:10.1080/08870446.2019.1622013 · Cited by 53
Structural requirements for cannabinoid-induced antinociceptive activity in mice
Martin, B. R. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90376-5 · Cited by 40
Aviram, J., Lewitus, G. M., Vysotski, Y., Uribayev, A., Procaccia, S., Cohen, I., Leibovici, A., Amna, M. A., Akria, L., Goncharov, D., et al. (2020) · Pharmaceuticals · doi:10.3390/ph13120435 · Cited by 43
Cannabis for Chronic Pain: Case Series and Implications for Clinicians
Ware, M. A., Gamsa, A., Persson, J., & Fitzcharles, M.-A. (2002) · Pain Research and Management · doi:10.1155/2002/380509 · Cited by 38
“Oral THC has been found to have some analgesic effect in cancer pain (10).”
BackgroundPeripheral analgesia: Hitting pain where it hurts
McDougall, J. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.011 · Cited by 44
“found that low dose ∆-9 tetrahydrocannabinol was equipotent to codeine in alleviating pain in cancer patients, although higher doses produced psychotropic side-effects such as ataxia, dizziness and blurred vision [81].”
BackgroundNatural products as a perspective for cancer pain management: A systematic review
Gouveia, D. N., Guimarães, A. G., Santos, W. B. D. R., & Quintans‐Júnior, L. J. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.026 · Cited by 38
Cannabinoids and pain responses: a possible role for prostaglandins
BURSTEIN, S. H., Hull, K. M., Hunter, S. A., & Latham, V. M. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.14.2846397 · Cited by 37
Potential therapeutic applications of naturally occurring and synthetic cannabinoids
Bhargava, H. N. (1978) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(78)90037-x · Cited by 37
Meng, H., Hanlon, J. G., Katznelson, R., Ghanekar, A., McGilvray, I. D., & Clarke, H. A. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-015-0525-6 · Cited by 40
“In a study examining analgesic equivalence of THC vs opioid in cancer pain patients, 10 mg and 20 mg of oral THC were found to be equipotent to 60 mg and 120 mg of oral codeine, respectively.(15) Although medical cannabis has not been approved by Health Canada as a therapeutic product, it has been used for pain in mul…”
BackgroundNigro, E., Formato, M., Crescente, G., & Daniele, A. (2021) · Molecules · doi:10.3390/molecules26092668 · Cited by 61
“Additionally, when using various THC dosages or synthetic analogs for cancer-related pain, an improved pain relief was found [164,165].”
BackgroundThe Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
Sexton, M., Garcia, J. M., Jatoi, A., Clark, C. S., & Wallace, M. S. (2021) · JNCI Monographs · doi:10.1093/jncimonographs/lgab011 · Cited by 44
“These studies reported increased pain relief over placebo but not compared with codeine (37,38).”
BackgroundClinical Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2004) · Journal of Cannabis Therapeutics · doi:10.1300/j175v04n01_03 · Cited by 43
The dose—Response relationship of controlled-release codeine (Codeine Contin) in chronic cancer pain
Chary, S., Goughnour, B. R., Moulin, D. E., Thorpe, W. R., Harsanyi, Z., & Darke, A. C. (1994) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)90173-2 · Cited by 35
Pergolizzi, J. V., LeQuang, J. A., & Bisney, J. (2018) · Medical Cannabis and Cannabinoids · doi:10.1159/000494992 · Cited by 39
Paradoxical effects of prophylactic phenothiazine antiemetics in children receiving chemotherapy.
Zeltzer, L. K., LeBaron, S., & Zeltzer, P. M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.8.930 · Cited by 34
Ortiz‐Peregrina, S., Ortíz, C., Castro, J. J., Jiménez, J. R., & Anera, R. G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17239033 · Cited by 32
“Other authors have suggested that cannabis could generate blurred vision [39].”
BackgroundPerspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We?
Palrasu, M., Wright, L. H., Patel, M. P., Leech, L., Branch, S., Harrelson, S., & Khan, S. R. (2022) · Medical Cannabis and Cannabinoids · doi:10.1159/000525629 · Cited by 44
State of the evidence: Cannabinoids and cancer pain—A systematic review
Tateo, S. (2016) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12422 · Cited by 38
“Both THC 20 mg and codeine 120 mg produced significant analgesia when compared to the placebo (p-value < .05; Noyes et al., 1975b).”
BackgroundMethodInfluentialMechoulam, R., & Feigenbaum, J. J. (1987) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(08)70422-3 · Cited by 35
Ramos, J., & Bianco, F. J. (2012) · Indian Journal of Urology · doi:10.4103/0970-1591.94942 · Cited by 34
“Initial studies quantified the modest efficacy of oral 20 mg D9-THC equivalent to 120 mg codeine with some sedation, dizziness, and confusion.[54,60,61] Recently in an observational study of patients with advanced cancer pain, nabilone reduced pain scores, total opioid requirements, and nausea.”
Uhelski, M. L., Cain, D. M., Harding-Rose, C., & Simone, D. A. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.05.003 · Cited by 37
“Two small clinical studies of the efficacy of delta-9-tetrohydrocannabinol for the treatment of advanced cancer pain found that patients reported pain relief comparable to codeine (Noyes et al., 1975a, b; 1976).”
BackgroundMedical uses of marijuana (Cannabis sativa): fact or fallacy?
Maule, W. J. (2015) · British Journal of Biomedical Science · doi:10.1080/09674845.2015.11666802 · Cited by 38
The medicinal uses of cannabis and its constituents
Formukong, E. A., EVANS, A. T., & Evans, F. J. (1989) · Phytotherapy Research · doi:10.1002/ptr.2650030602 · Cited by 36
Papanastassiou, A. M., Fields, H. L., & Meng, I. D. (2003) · Pain · doi:10.1016/j.pain.2003.11.009 · Cited by 29
“Cannabinoid compounds are effective analgesics for cancer and post-operative pain (Campbell et al., 2001; Jain et al., 1981; Noyes et al., 1975a,b).”
BackgroundProgress toward Understanding the Cannabinoid Receptor and Its Second Messenger Systems
Martin, B. R., Welch, S. P., & Abood, M. E. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60437-8 · Cited by 31
Chemistry and pharmacology of cannabis
Seth, R., & Sinha, S. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7136-5_3 · Cited by 27
Das, V., Kalyan, G., Hazra, S., & Pal, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25821 · Cited by 28
Effects of cannabis on visual function and self-perceived visual quality
Ortiz‐Peregrina, S., Ortíz, C., Casares‐López, M., Jiménez, J. R., & Anera, R. G. (2021) · Scientific Reports · doi:10.1038/s41598-021-81070-5 · Cited by 34
Deusch, E., Kraft, B., Nahlik, G., Weigl, L. G., HOHENEGGER, M., & Kress, H. G. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00259-5 · Cited by 25
“Other potential indications are pain relief (Noyes et al., 1975; Meng et al., 1998) in certain conditions like multiple sclerosis (Martyn et al., 1995) and spasticity (Petro and Ellenberger, 1981).”
BackgroundKalliomäki, J., Philipp, A., Baxendale, J., Annas, P., Karlsten, R., & Segerdahl, M. (2012) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2012.05674.x · Cited by 27
Stein, E. A., Fuller, S. A., Edgemond, W. S., & Campbell, W. B. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00043-8 · Cited by 25
“Among its mechanisms of action, D9 THC is thought to modulate pain threshold by altering the perception, and/or the affective appreciation of the sensory stimulus (Noyes et al. 1975).”
BackgroundHanks, G. W. (1984) · Postgraduate Medical Journal · doi:10.1136/pgmj.60.710.881 · Cited by 25
Aviram, J., Lewitus, G. M., Vysotski, Y., Amna, M. A., Ouryvaev, A., Procaccia, S., Cohen, I., Leibovici, A., Akria, L., Goncharov, D., et al. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.861037 · Cited by 28
A Dramatic Response to Inhaled Cannabis in a Woman with Central Thalamic Pain and Dystonia
Chatterjee, A., Almahrezi, Ware, & Fitzcharles (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00426-8 · Cited by 24
Analysis of the Medical Use of Marijuana and its Societal Implications
Taylor, H. G. (1998) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30318-7 · Cited by 24
Contrast sensitivity and motion discrimination in cannabis users
Mikulskaya, E., & Martin, F. H. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4944-2 · Cited by 28
Metadata
- Authors
- Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A.
- Affiliations
- University of Iowa (US)
- ORCID
- Avery, David H.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1975-07
- Volume
- 18
- Issue
- 1
- Pages
- 84-89
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2415446085
- Cited by
- 378
- References
- 4
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 15 · 2023: 14 · 2022: 20 · 2021: 10 · 2020: 16 · 2019: 10 · 2018: 18 · 2017: 11 · 2016: 15 · 2015: 7 · 2014: 11 · 2013: 8 · 2012: 11
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Keywords
- delta-9-tetrahydrocannabinol, codeine, analgesia, cancer pain, oral administration, adverse drug reactions, sedation, dose-response relationship, drug tolerance
- MeSH terms
- Analgesics, Aspirin, Cannabis, Clinical Trials as Topic, Codeine, Drug Therapy, Combination, Female, Humans, Male, Phytotherapy, Middle Aged, Neoplasms, Pain, Palliative Care, Placebos, Dextropropoxyphene, Dronabinol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.